Literature DB >> 8078737

Comparison of vertical human immunodeficiency virus type 2 and human immunodeficiency virus type 1 transmission in the French prospective cohort. The HIV Infection in Newborns French Collaborative Study Group.

.   

Abstract

In the French prospective cohort study we compared the mother-infant transmission rates of human immunodeficiency virus type 1 (HIV-1) and human immunodeficiency virus type 2 (HIV-2). As of January 1, 1994, 86 infants born to 68 HIV-2-seropositive mothers have been included in the cohort. Forty-one children had been followed up for more than 18 months at the time of analysis. During the same period 1758 infants born to 1589 HIV-1-infected mothers were included; 419 mothers were of African origin. One thousand one hundred fifteen children had a follow-up of 18 months or more; 260 of these were of African origin. The HIV-2 transmission rate, based on serologic status at 18 months, was 0% (95% confidence interval, 0 to 11%). This was significantly lower than the HIV-1 transmission rate of 21% (confidence interval, 16 to 26%) in infants born to African mothers. The difference remained significant when the comparison was extended to HIV-1-positive women of French origin infected by the sexual route or by iv drug abuse. Most of the HIV-2-infected women were from West Africa; they were older and had more children than the HIV-1-infected women. The circulating CD4+ lymphocyte count was significantly higher in these women than in the HIV-1-infected mothers. Reported differences in the replication of the two viruses probably account for the lower mother-infant transmission rate of HIV-2.

Entities:  

Mesh:

Year:  1994        PMID: 8078737

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  6 in total

1.  A Trial of a Single-tablet Regimen of Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate for the Initial Treatment of Human Immunodeficiency Virus Type 2 Infection in a Resource-limited Setting: 48-Week Results From Senegal, West Africa.

Authors:  Selly Ba; Dana N Raugi; Robert A Smith; Fatima Sall; Khadim Faye; Stephen E Hawes; Papa Salif Sow; Moussa Seydi; Geoffrey S Gottlieb
Journal:  Clin Infect Dis       Date:  2018-10-30       Impact factor: 9.079

Review 2.  Mother-to-child transmission of human immunodeficiency virus type 1.

Authors:  G C John; J Kreiss
Journal:  Epidemiol Rev       Date:  1996       Impact factor: 6.222

3.  Changing HIV epidemics: what HIV-2 can teach us about ending HIV-1.

Authors:  Geoffrey S Gottlieb
Journal:  AIDS       Date:  2013-01-02       Impact factor: 4.177

Review 4.  Prevention of maternal HIV transmission. Practical guidelines.

Authors:  C Rouzioux
Journal:  Drugs       Date:  1995       Impact factor: 9.546

5.  Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants.

Authors:  Sabelle Jallow; Abraham Alabi; Ramu Sarge-Njie; Kevin Peterson; Hilton Whittle; Tumani Corrah; Assan Jaye; Matthew Cotten; Guido Vanham; Samuel J McConkey; Sarah Rowland-Jones; Wouter Janssens
Journal:  J Clin Microbiol       Date:  2009-05-06       Impact factor: 5.948

6.  [HIV-2 infection in Senegal: virological failures and resistance to antiretroviral drugs (ARVs)].

Authors:  Selly Ba; Ndeye Mery Dia-Badiane; Stephen Edward Hawes; Louise Fortes Deguenonvo; Fatima Sall; Cheikh Tidiane Ndour; Khadim Faye; Fatou Traoré; Macoumba Touré; Marie Pierre Sy; Dana Noelle Raugi; Nancy Berenice Kiviat; Robert Alexander Smith; Moussa Seydi; Papa Salif Sow; Geoffrey Scott Gottlieb
Journal:  Pan Afr Med J       Date:  2019-07-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.